These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3042682)

  • 1. [Disorders of receptor function as a pathogenetic principle in myasthenia gravis].
    Toyka KV
    Internist (Berl); 1988 Jun; 29(6):414-9. PubMed ID: 3042682
    [No Abstract]   [Full Text] [Related]  

  • 2. The pathogenesis of myasthenia gravis.
    Heilbronn E; Stålberg E
    J Neurochem; 1978 Jul; 31(1):5-11. PubMed ID: 209148
    [No Abstract]   [Full Text] [Related]  

  • 3. Myasthenia gravis: a model disorder of acetylcholine receptors.
    Drachman DB
    Res Publ Assoc Res Nerv Ment Dis; 1987; 65():65-82. PubMed ID: 3330842
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical significance of immune complexes at the motor endplate in myasthenia gravis].
    Tsujihata M; Yoshimura T; Satoh A; Hazama R; Mori M
    Rinsho Shinkeigaku; 1983 Sep; 23(9):735-43. PubMed ID: 6673871
    [No Abstract]   [Full Text] [Related]  

  • 5. [Myasthenia gravis: biochemical and immunological aspects, status of research. (I)].
    Maufort-Nortier J
    Rev Med Brux; 1984 Nov; 5(9):579-88. PubMed ID: 6395256
    [No Abstract]   [Full Text] [Related]  

  • 6. [Myasthenia gravis. Prototype of an anti-receptor autoaggression disease (author's transl)].
    Hohlfeld R; Wekerle H
    MMW Munch Med Wochenschr; 1981 Jul; 123(31):1207-11. PubMed ID: 6790965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental myasthenia: lack of correlation between the autoantibody titer and the reduction of acetylcholine-controlled ionic channels measured at functioning endplates.
    Hohlfeld R; Sterz R; Kalies I; Wekerle H; Peper K
    Muscle Nerve; 1983 Feb; 6(2):160-3. PubMed ID: 6304508
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunopathologic events at the endplate in myasthenia gravis.
    Ashizawa T; Appel SH
    Springer Semin Immunopathol; 1985; 8(3):177-96. PubMed ID: 2413561
    [No Abstract]   [Full Text] [Related]  

  • 9. Short review of progress in experimental myasthenia gravis, bearing on the pathogenesis of myasthenia gravis.
    Heilbronn E
    Prog Brain Res; 1979; 49():459-63. PubMed ID: 390612
    [No Abstract]   [Full Text] [Related]  

  • 10. The immunopathology of myasthenia gravis.
    Engel AG
    Int J Neurol; 1980; 14(1):35-46. PubMed ID: 6293990
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunobiology of myasthenia gravis, experimental autoimmune myasthenia gravis, and Lambert-Eaton syndrome.
    Lindstrom J
    Annu Rev Immunol; 1985; 3():109-31. PubMed ID: 2998417
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental autoimmune myasthenia gravis and cholinergic ionophore: an electrophysiologic study.
    Takamori M; Mori M; Kasai M
    Neurology; 1979 Jul; 29(7):945-50. PubMed ID: 572943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-acetylcholine receptor antibodies induced in mice by syngeneic receptor without adjuvants.
    Scadding GK; Calder L; Vincent A; Prior C; Wray D; Newsom-Davis J
    Immunology; 1986 May; 58(1):151-5. PubMed ID: 3486818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Myasthenia gravis (2). Antibodies against acetylcholinergic receptros in myasthenia gravis].
    Bergström K; Lefvert AK
    Lakartidningen; 1978 Oct; 75(41):3665-7. PubMed ID: 692232
    [No Abstract]   [Full Text] [Related]  

  • 15. Myasthenia induced by monoclonal anti-acetylcholine receptor antibodies: clinical and electrophysiological aspects.
    Burres SA; Crayton JW; Gomez CM; Richman DP
    Ann Neurol; 1981 Jun; 9(6):563-8. PubMed ID: 6167199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acetylcholine receptor antibodies in myasthenia gravis].
    Yakirevich V; Snir E; Brener T; Borenstein N; Vidne BA
    Harefuah; 1983 Apr; 104(7):269-70. PubMed ID: 6618324
    [No Abstract]   [Full Text] [Related]  

  • 17. Myasthenia gravis. Laboratory and clinical analysis of 120 cases.
    Xu XH
    Chin Med J (Engl); 1986 Jul; 99(7):555-60. PubMed ID: 3100203
    [No Abstract]   [Full Text] [Related]  

  • 18. Myasthenia gravis and autoantibodies.
    Nishitani H
    Jpn J Med; 1988 May; 27(2):228-9. PubMed ID: 3418994
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antibodies to acetylcholine receptor. Diagnosis and therapeutic interest in myasthenia gravis (author's transl)].
    de Crousaz G
    Ann Chir; 1980 Mar; 34(3):188-92. PubMed ID: 7369693
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies of human myasthenia gravis: electrophysiological and ultrastructural evidence compatible with antibody attachment to acetylcholine receptor complex.
    Rash JE; Albuquerque EX; Hudson CS; Mayer RF; Satterfield JR
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4584-8. PubMed ID: 1070009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.